Trial Profile
Phase II Trial of CCI-779 in Locally Advanced or Metastatic Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary)
- Indications Pancreatic cancer
- Focus Biomarker; Therapeutic Use
- 20 Sep 2005 New trial record.